On the contrary, some studies recently associated low NKG2A+ cell frequencies or low-level NKG2A expression with an increased risk and a worse clinical prognosis of autoimmune diseases, such as systemic lupus erythematosus, psoriasis, and rheumatoid arthritis (32, 38). This evidence concerns the gene KLRC1 and psoriasis.